Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2.

doi:10.1016/j.semradonc.2015.09.004

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2.

Seminars in radiation oncology - 1 Jan 2016

Scalia-Wilbur Jennifer, Colins Bradley L, Penson Richard T, Dizon Don S

Abstract excerpt

The National Cancer Institute estimates that 12.3% of all women (about 1 in 8) would be diagnosed with breast cancer throughout their lifetime. In 2015, a projected 231,840 new cases are expected in the United States, accompanied by 40,290 deaths. Presently, breast cancer is responsible for 6.8% of all cancer deaths, and roughly 30% of all cancers in women. Since the discovery of the BRCA gene in 1994, efforts...

Topics

Breast Neoplasms
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Genetic Testing
Humans
Risk Assessment

Source

Open in PubMed

Identifiers

PMID: 26617204
DOI: 10.1016/j.semradonc.2015.09.004

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics